Progress on cholesterol metabolism and non-alcoholic steatohepatitis

Progress on cholesterol metabolism and non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD). Cholesterol is an essential substance for biological process. Intestinal absorption of dietary cholesterol, as well as circulating lipoprotein exchange, intracellular cholesterol synthesis and me...

Full description

Bibliographic Details
Main Author:	LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2022-07-01
Series:	Jichu yixue yu linchuang
Subjects:	cholesterol\|non-alcoholic steatohepatitis\|macrophage\|inflammation\|bile acid
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-7-1134.pdf

Similar Items

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
by: Oksana Khukhlina, et al.
Published: (2021-05-01)

Medicinal Formula Huazhi-Rougan Attenuates Non-Alcoholic Steatohepatitis Through Enhancing Fecal Bile Acid Excretion in Mice
by: Chunlin Li, et al.
Published: (2022-06-01)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
by: Xiangbing Shu, et al.
Published: (2021-09-01)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
by: Jie Jian, et al.
Published: (2022-04-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
by: Daryl Ramai, et al.
Published: (2021-02-01)

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
by: Nana Makiuchi, et al.
Published: (2023-09-01)

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
by: T. Antofiichuk, et al.
Published: (2023-05-01)

Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice
by: Xiaoxiao Li, et al.
Published: (2024-11-01)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
by: Sina Ghandian, et al.
Published: (2022-03-01)

G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
by: Xiaoli Wei, et al.
Published: (2023-03-01)

Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis
by: Dong Hun Lee, et al.
Published: (2022-12-01)

Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
by: Akihide Kamiya, et al.
Published: (2022-11-01)

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis
by: Yuta Hirata, et al.
Published: (2024-12-01)

Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet
by: Yuta Miyaoka, et al.
Published: (2017-07-01)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
by: Yu Junjie, et al.
Published: (2023-01-01)

The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Chunye Zhang, et al.
Published: (2022-04-01)

Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice
by: Shu‐Chen Cheng, et al.
Published: (2024-03-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
by: Janet Sánchez-Quevedo, et al.
Published: (2022-09-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
by: Xia Ziqiang, et al.
Published: (2023-01-01)

Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice
by: Jia Xu, et al.
Published: (2022-05-01)

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
by: Chunye Zhang, et al.
Published: (2023-10-01)

Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Tharani Senavirathna, et al.
Published: (2024-04-01)

Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
by: Merve Cebi, et al.
Published: (2024-08-01)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
by: Qingfu Zhu, et al.
Published: (2022-07-01)

Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis
by: Donglin Liu, et al.
Published: (2024-06-01)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
by: Ana Šinkovec, et al.
Published: (2021-10-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Combination of autoimmune hepatitis to non-alcoholic steatohepatitis (Clinical case)
by: A. A. Driga, et al.
Published: (2010-11-01)

Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis
by: Nancy Magee, et al.
Published: (2022-12-01)

Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis
by: Ryota Murata, et al.
Published: (2024-02-01)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
by: Kyoungbun Lee, et al.
Published: (2020-05-01)

Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis
by: Bowen Gao, et al.
Published: (2023-09-01)

Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways
by: Ziheng Wei, et al.
Published: (2021-09-01)

Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis
by: David J. Matye, et al.
Published: (2022-12-01)

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics
by: Fei Xia, et al.
Published: (2024-08-01)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
by: Hyeong Geug Kim, et al.
Published: (2021-07-01)